HighMark Wealth Management LLC holds a focused book of 559 stocks worth $298.5M as of Q2 2026 (disclosed Aug 12, 2026, a ~43-day 13F lag). This quarter they opened Apogee Therapeutics Inc and trimmed Ishares Core S&P 500 ETF. Their largest long position is Ishares Core S&P 500 ETF at 28% of the equity book. They also disclosed $19 in put options (a bearish bet) and $325 in call options (bullish), shown separately below and excluded from the equity book.
Top-heavy: focused book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
35% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices, no cost basis
Other tracked managers holding the same core names as HighMark Wealth Management LLC
| Manager / fund | Shared names | Their $ in those |
|---|---|---|
| FMR LLC | 80 / 80 | $695.4B |
| MORGAN STANLEY | 80 / 80 | $513.4B |
| JPMORGAN CHASE & CO | 80 / 80 | $491.8B |
| BANK OF AMERICA CORP /DE/ | 80 / 80 | $382.8B |
| UBS Group AG | 80 / 80 | $133.5B |
| Russell Investments Group, Ltd. | 80 / 80 | $26.8B |
| BlackRock, Inc. | 79 / 80 | $2.0T |
| GOLDMAN SACHS GROUP INC | 79 / 80 | $251.2B |
Ranked by how many of HighMark Wealth Management LLC's top 80 disclosed names each fund also holds: a cross-fund conviction signal from the latest 13F of every tracked manager.
Bars show each stock's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Ishares TR CORE S&P500 ETF | $82.3M | 109.9K | 27.6% | ▼−6.0% Reduced · −7K sh | |
| 2 | Fidelity Covington Trust MSCI HLTH CARE I | $19.7M | 254.4K | 6.6% | ▲32k× Added · +254K sh | |
| 3 | Axogen Inc COM | $15.8M | 341.4K | 5.3% | ▼−1.0% Reduced · −4K sh | |
| 4 | Ishares TR RUSSELL 2000 ETF | $15.3M | 51.0K | 5.1% | ▼−6.6% Reduced · −4K sh | |
| 5 | Ishares TR EAFE VALUE ETF | $15.2M | 199.2K | 5.1% | ▼−9.6% Reduced · −21K sh | |
| 6 | Ishares TR CORE S&P SCP ETF | $13.3M | 89.9K | 4.5% | ▼−0.9% Reduced · −797 sh | |
| 7 | Vanguard Index FDS S&P 500 ETF SHS | $10.7M | 15.5K | 3.6% | ▼−5.9% Reduced · −982 sh | |
| 8 | Neogenomics Inc COM NEW | $8.9M | 612.5K | 3.0% | ▲+5.6% Added · +33K sh | |
| 9 | Ishares TR CORE S&P US VLU | $8.3M | 75.5K | 2.8% | ▼−6.2% Reduced · −5K sh | |
| 10 | Si Bone Inc COM | $6.9M | 425.0K | 2.3% | ▲+166% Added · +265K sh | |
| 11 | Invesco Exch Traded FD TR II DORSEY WRGT SMLC | $5.9M | 46.5K | 2.0% | ▼−0.7% Reduced · −319 sh | |
| 12 | Wells Fargo &CO COM | $5.7M | 68.6K | 1.9% | ▲+0.1% Added · +47 sh | |
| 13 | Ishares TR CORE S&P MCP ETF | $4.8M | 62.4K | 1.6% | ▲+2.8% Added · +2K sh | |
| 14 | Apogee Therapeutics Inc COM | $4.3M | 32.3K | 1.4% | ▲New New position | |
| 15 | Twist Bioscience Corp COM | $4.0M | 39.0K | 1.3% | ▼−0.7% Reduced · −260 sh | |
| 16 | Duos Technologies Group Inc COM | $3.5M | 289.9K | 1.2% | ▲New New position | |
| 17 | Ishares TR 20 YR TR BD ETF | $3.1M | 36.1K | 1.0% | ▲+1.0% Added · +372 sh | |
| 18 | 908 Devices Inc COM | $3.0M | 339.8K | 1.0% | ▲+6.4% Added · +20K sh | |
| 19 | Anaptysbio Inc COM | $2.7M | 39.7K | 0.9% | ▼−58% Reduced · −54K sh | |
| 20 | Neuropace Inc COM | $2.6M | 163.0K | 0.9% | ▲+159% Added · +100K sh | |
| 21 | Nvidia Corporation COM | $2.4M | 11.8K | 0.8% | ▼−7.3% Reduced · −931 sh | |
| 22 | Atricure Inc COM | $2.3M | 83.7K | 0.8% | —Held | |
| 23 | Apple Inc COM | $2.2M | 7.6K | 0.7% | ▼−3.0% Reduced · −232 sh | |
| 24 | Edgewise Therapeutics Inc COM | $2.2M | 53.2K | 0.7% | —Held | |
| 25 | Eli Lilly &CO COM | $2.1M | 1.7K | 0.7% | ▲+0.3% Added · +6 sh | |
| 26 | Travelers Companies Inc COM | $1.9M | 5.6K | 0.6% | ▲+0.6% Added · +31 sh | |
| 27 | Microsoft Corp COM | $1.7M | 4.7K | 0.6% | ▲+4.0% Added · +178 sh | |
| 28 | Health Catalyst Inc COM | $1.7M | 871.1K | 0.6% | ▼−3.5% Reduced · −32K sh | |
| 29 | 3M Co COM | $1.6M | 9.7K | 0.5% | ▼−0.3% Reduced · −28 sh | |
| 30 | Ishares TR S&P MC 400VL ETF | $1.5M | 10.0K | 0.5% | ▲+7.8% Added · +724 sh | |
| 31 | Crinetics Pharmaceuticals In COM | $1.4M | 38.6K | 0.5% | ▲+88% Added · +18K sh | |
| 32 | Ishares TR RUS 2000 VAL ETF | $1.4M | 6.5K | 0.5% | ▲+7.5% Added · +455 sh | |
| 33 | Xenon Pharmaceuticals Inc COM | $1.4M | 23.0K | 0.5% | —Held | |
| 34 | Ishares TR S&P 500 VAL ETF | $1.3M | 5.9K | 0.4% | ▲+2.9% Added · +167 sh | |
| 35 | Tesla Inc COM | $1.2M | 2.8K | 0.4% | ▲~0% Added · +1 sh | |
| 36 | Xcel Energy Inc COM | $1.1M | 13.1K | 0.4% | ▲+0.5% Added · +68 sh | |
| 37 | Ishares TR IBOXX INV CP ETF | $1.0M | 9.3K | 0.3% | ▲+3.7% Added · +337 sh | |
| 38 | US Bancorp COM NEW | $1.0M | 16.6K | 0.3% | ▼−1.9% Reduced · −326 sh | |
| 39 | Vanguard Index FDS TOTAL STK MKT | $919K | 2.5K | 0.3% | ▲+0.3% Added · +7 sh | |
| 40 | Ishares TR CORE US AGGBD ET | $914K | 9.2K | 0.3% | ▲+2.0% Added · +179 sh | |
| 41 | HSBC Hldgs PLC SPON ADR NEW | $857K | 9.0K | 0.3% | —Held | |
| 42 | State STR SPDR S&P 500 ETF T TR UNIT | $807K | 1.1K | 0.3% | ▼−3.6% Reduced · −41 sh | |
| 43 | Alphabet Inc CAP STK CL A | $784K | 2.2K | 0.3% | ▲+8.2% Added · +167 sh | |
| 44 | Procter &Gamble Co COM | $764K | 5.2K | 0.3% | ▲+1.4% Added · +72 sh | |
| 45 | Amazon Com Inc COM | $711K | 3.0K | 0.2% | ▲+5.2% Added · +148 sh | |
| 46 | SPDR Index SHS FDS ST PORT MARK ETF | $695K | 13.4K | 0.2% | ▼−10% Reduced · −2K sh | |
| 47 | Aurinia Pharmaceuticals Inc COM | $597K | 35.2K | 0.2% | —Held | |
| 48 | Ecolab Inc COM | $585K | 2.1K | 0.2% | ▲+0.3% Added · +6 sh | |
| 49 | Altria Group Inc COM | $568K | 7.9K | 0.2% | ▲+1.6% Added · +121 sh | |
| 50 | J P Morgan Exchange Traded F U S TEC LEA ETF | $567K | 5.1K | 0.2% | ▲+195% Added · +3K sh |
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/1802451/holdings"
Use Arkolith to show HighMark Wealth Management LLC's latest holdings, largest changes, and filing provenance.
Put / call positions from the 13F — totals include every disclosed option leg
| Type | Underlying | Notional value | Underlying shares |
|---|---|---|---|
| CALL · bullish | DEFINIUM THERAPEUTICS INC | $265 | 1 |
| CALL · bullish | WENDYS CO | $60 | 1 |
| PUT · bearish | STATE STR SPDR S&P 500 ETF T | $19 | 19 |
13F filers disclose option positions at the market value of the underlying the contracts reference, not the premium paid. A put is a bearish bet (it gains if the stock falls); a call is bullish. “Underlying shares” is the share count the contracts control, not a share holding. These legs are excluded from the equity book, weighting, concentration and sector figures above.
As-of date vs the date the SEC received each filing
Holdings from SEC EDGAR 13F-HR filings, updated quarterly, filed up to 45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. Price-derived performance is withheld until the price-source policy and freshness gate are green.